IGC Pharma (IGC) Stock: Buy, Sell, or Hold?

IGC - IGC Pharma, Inc.

PHARMACEUTICAL PREPARATIONS
$0.25
0.00 (-0.69%) ▼
5d: +0.0%
30d: -12.49%
90d: -6.46%
BUY
HIGH Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 13, 2026 19d

Get Alerted When IGC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: IGC shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: IGC is currently trading at $0.25, which is considered oversold relative to its 30-day fair value range of $0.25 to $0.28.

Technical Outlook: Technically, IGC is in a uptrend. Immediate support is located at $0.23, while resistance sits at $0.28.

Market Sentiment: IGC scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.00 (+2339.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $0.25 - $0.28
Company Quality Score 61/100 (BUY)
Volume Confirmation HIGH
Confidence Score 94.7%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Strong technical setup (72/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 2339.0% below Wall St target ($6.00)
  • BULLISH: Bottoming setup score 72/100 — corrected, stabilizing, and turning up

Trading Range Analysis

30-Day Trading Range $0.25 - $0.28
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $0.24
Resistance Level $0.29
Current Trend Uptrend
Technical data as of Oct 23, 2026

Fundamental Context

Forward P/E (Next Year Est.) -2.73
Wall Street Target $6.00 (+2339.0%)
Revenue Growth (YoY) -19.2%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 24, 2026 4:38 AM ET
Data refreshes hourly during market hours. Next update: 5:38 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
22 analysts
$295 64 BUY
REGN
Regeneron Pharmaceutical…
BUY
28 analysts
$864 35 SELL
ELVN
Enliven Therapeutics Inc.
STRONG BUY
14 analysts
$74 65 BUY
ACAD
ACADIA Pharmaceuticals I…
STRONG BUY
20 analysts
$31 61 BUY
DYN
Dyne Therapeutics Inc
STRONG BUY
17 analysts
$36 47 HOLD

More Analysis for IGC

IGC Technical Chart IGC Price Prediction IGC Earnings Date IGC Investment Advisor IGC Fair Price Analyzer IGC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals